Walden Biosciences to Host Virtual Event on November 14, 2023 "Transforming the Treatment Landscape of Chronic Kidney Disease"

Walden Biosciences to Host Virtual Event on November 14, 2023 "Transforming the Treatment Landscape of Chronic Kidney Disease"

Grand News Network / November 7, 2023 12:15 PM

Virtual event to include overview of Walden's development programs and fireside chats highlighting the CKD landscape with Key Opinion Leaders

Webcast to begin at 11:00 AM EST

CAMBRIDGE, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Walden Biosciences, Inc. (Walden), a private, venture-backed clinical-stage company focused on transforming the treatment of kidney diseases, today announced that management will host a virtual event titled, "Transforming the Treatment Landscape of Chronic Kidney Disease," (CKD) on November 14, 2023 from 11:00 a.m. to 12:30 p.m. EST.

The program will include remarks from executive and scientific management relating to Walden's clinical and preclinical programs, where they are pursuing disease-modifying treatments for kidney diseases.

Alexander Duncan, Ph.D., Chief Scientific Officer and Thomas Miller, Ph.D., Senior Vice President, Head of Research, will review Walden's novel ...

Full story available on Benzinga.com


Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.


Disclaimer Press Release Banner

Market Details

Copyright © 2024 | All rights reserved